Literature DB >> 17578198

[Pleural metastases of renal carcinoma].

O G Giigoruk, A F Lazarev, V S Doroshenko.   

Abstract

Metastases in renal carcinoma are diagnosed at initial diagnosis in 25% examinees. Traditional renal carcinoma has higher metastatic potential, is associated with worse survival of the patients compared to papillary cancer. We studied cytological characteristics of renal carcinoma metastases to the pleura in comparison with histological studies of the primary lesion using immunohistochemical findings. We examined cytologically pleural liquid in renal carcinoma metastases to the pleura in 6 patients (2.3% of carcinomatous pleuricies). High efficacy was shown by a cytocentrifuge CYTOSPIN-4. In 3 cases initial cancer was renal cell carcinoma, pleural exudation developed 2 years later, clear cell carcinoma appeared 6 years later and papillary cancer--10 years later. In the other 3 cases malignant cells were detected in new-onset cases. Renal carcinoma was diagnosed in one case. Cytological preparations were studied with identification of cytological signs typical for classic clear cell, granulocell and papillary renal cancer. Immunohistochemical examination of primary tumor lesion in the kidney discovered high proliferative activity of tumor cells by Ki-67 index to 5.28%. The tumors had solitary Bcl-2 positive cells. Expression of mutant p-53 took place in 0.93%. Her-2/neu hyperexpression was not found in the tumors of the above patients. Such immunohistochemical parameters point to poor prognosis. This is confirmed by renal carcinoma metastases to the pleura.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578198

Source DB:  PubMed          Journal:  Urologiia        ISSN: 1728-2985


  1 in total

1.  Renal cell carcinoma with atypical metastases sites revealed by diabetes mellitus: A case report.

Authors:  Nejmeddine Jelleli; Ahmed Loghmari; Oussama Belkacem; Ghassen Tlili; Bilel Jellali; Sabrine Chouaya; Khaireddine Bouassida; Wissem Hmida; Mehdi Jaidane; Sihem Hmissa
Journal:  Ann Med Surg (Lond)       Date:  2022-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.